Kuhrts, CA
Eric Kuhrts, Bodega, CA US
Patent application number | Description | Published |
---|---|---|
20090209654 | Prenylflavonoid Formulations - Methods and formulations for increasing the water solubility and/or bioavailability of prenylfiavonoids are disclosed. The formulations may be employed to treat a disease states, including cancer. | 08-20-2009 |
20100160450 | METHODS OF REDUCING 15-F2T-ISOP LEVELS IN MAMMALS - Methods of reducing 15-F2t-IsoP levels in mammalian subjects are disclosed herein. In addition, methods of reducing or preventing oxidative stress and treating or preventing related diseases are disclosed. | 06-24-2010 |
20100330215 | Methods of Administering Anti-Inflammatory Cyclooxygenase-2 Selective Inhibitors - Disclosed are novel anti-inflammatory pharmaceutical compositions and related methods that exhibit potent and selective inhibition of the cycloooxygenase-2 (COX-2) enzyme. The formulation can comprise a hops extract that exhibits COX-2 selectivity as defined by dividing the IC50 COX-2/IC50COX-1 concentrations that are determined by testing with the William Harvey Whole Blood Assay (WHMA), and can fall within the range of 0.011 to 0.2. Such compositions may also optionally contain high levels of alpha acids and low levels of beta acids, some flavonoid compounds, and virtually no essential oils. Such compositions are useful for treating conditions that manifest as inflammatory pain, or are impacted by the COX-2 enzyme. The recited compositions are particularly beneficial for treating osteoarthritis and rheumatoid arthritis, and can be used for chronic pain with reduced gastric side-effects. | 12-30-2010 |
20110003888 | HOPS EXTRACTION METHODS AND MIXTURES - Methods and mixtures for extracting prenylflavonoids from prenylflavonoid-containing hops materials are provided. | 01-06-2011 |
20110281957 | ENHANCED BIOACTIVE FORMULATIONS OF RESVERATROL - Methods and formulations for increasing the water solubility and/or bioavailability of resveratrol are disclosed. The formulations may be employed to treat a disease states, including cancer. | 11-17-2011 |
20120059052 | PRENYLFLAVONOID FORMULATIONS - Methods and formulations for increasing the water solubility and/or bioavailability of prenylfiavonoids are disclosed. The formulations may be employed to treat a disease states, including cancer. | 03-08-2012 |
20130123368 | METHODS OF REDUCING 15-F2T-ISOP LEVELS IN MAMMALS - Methods of reducing 15-F | 05-16-2013 |
20130287923 | TASTE MASKING FORMULATIONS OF FATTY ACIDS - Methods and formulations for improving the sensory characteristics and stability of dietary fatty acids for use in beverages, liquid concentrates, or other formulations are disclosed. | 10-31-2013 |
20150224074 | STABLE FORMULATIONS OF FATTY ACIDS - Methods and formulations for increasing the water solubility and/or stability of dietary fatty acids are disclosed. | 08-13-2015 |
Eric Kuhrts, Novato, CA US
Patent application number | Description | Published |
---|---|---|
20140235715 | TASTE MASKING FORMULATIONS OF FATTY ACIDS - Methods and formulations for improving the sensory characteristics and stability of dietary fatty acids for use in beverages, liquid concentrates, or other formulations are disclosed. | 08-21-2014 |
Eric H. Kuhrts, Novato, CA US
Patent application number | Description | Published |
---|---|---|
20130245118 | STABLE FATTY ACID-CONTAINING FORMULATIONS - Methods and formulations for increasing the water solubility, stability, shelf life, and/or bioavailability of dietary fatty acids are disclosed. The formulation can comprise a dietary fatty acid, a non-ionic surfactant, a flavonoid or polyphenol, and optionally, water. | 09-19-2013 |
20140023599 | WATER-SOLUBLE PHARMACEUTICAL COMPOSITIONS OF HOPS RESINS - The present invention is drawn to water-soluble compositions for providing hops constituents, particularly alpha acids, iso-alpha acids, and beta acids. A pharmaceutical gel composition can comprise a hops extract and a surfactant. Such compositions can be formulated into products for various therapeutic applications, including oral and topical uses. Such compositions can also be dissolved in water to yield a clear solution containing more dilute hops acids. The invention also provides methods of treatment comprising administering water-soluble hops compositions. The present invention is also drawn to methods for making water-soluble preparations of hops constituents. | 01-23-2014 |
Eric H. Kuhrts, Fairfield, CA US
Patent application number | Description | Published |
---|---|---|
20150290266 | WATER-SOLUBLE PHARMACEUTICAL COMPOSITIONS OF HOPS RESINS - The present invention is drawn to water-soluble compositions for providing hops constituents, particularly alpha acids, iso-alpha acids, and beta acids. A pharmaceutical gel composition can comprise a hops extract and a surfactant. Such compositions can be formulated into products for various therapeutic applications, including oral and topical uses. Such compositions can also be dissolved in water to yield a clear solution containing more dilute hops acids. The invention also provides methods of treatment comprising administering water-soluble hops compositions. The present invention is also drawn to methods for making water-soluble preparations of hops constituents. | 10-15-2015 |
Eric Hauser Kuhrts, Bodega, CA US
Patent application number | Description | Published |
---|---|---|
20120270951 | NOVEL ANTI-INFLAMMATORY CYCLOOXYGENASE INHIBITORS - Disclosed is a pharmaceutical composition including a therapeutic quantity of a COX-2 inhibitor having an IC50-WHMA COX-2/COX-1 ratio ranging from about 0.23 to about 3.33 with reduced gastrointestinal and cardiovascular toxicity. Also disclosed are methods for treating osteoarthritis, rheumatoid arthritis or acute pain with less side-effects and faster onset of action utilizing the disclosed pharmaceutical composition. | 10-25-2012 |
20140045904 | NIACIN FORMULATIONS AND METHODS WITH REDUCED FLUSHING SIDE EFFECT - Compositions and methods for reducing the flushing effect (cutaneous erythema) of niacin and for treating hyper lipemia and elevated triglycerides, comprising a prenylflavonoid, such as xanthohumol, and niacin (nicotinic acid or Vitamin B3). | 02-13-2014 |
20140066520 | NOVEL ANTI-INFLAMMATORY CYCLOOXYGENASE INHIBITORS - Disclosed is a pharmaceutical composition including a therapeutic quantity of a COX-2 inhibitor having an IC50-WHMA COX-2/COX-1 ratio ranging from about 0.23 to about 3.33 with reduced gastrointestinal and cardiovascular toxicity. Also disclosed are methods for treating osteoarthritis, rheumatoid arthritis or acute pain with less side-effects and faster onset of action utilizing the disclosed pharmaceutical composition. | 03-06-2014 |
Eric Hauser Kuhrts, Novato, CA US
Patent application number | Description | Published |
---|---|---|
20150182625 | WATER-SOLUBLE LIPOPHILIC NATURAL COMPOUND FORMULATIONS - Methods and formulations for increasing the water solubility and/or bioavailability of a lipophilic natural compounds is disclosed. The formulations may be employed to make liquid filled capsules or clear and stable beverages containing therapeutic amounts of the active ingredients, for example. | 07-02-2015 |
20150209307 | COMPOSITIONS AND METHODS FOR TREATING MOOD DISORDERS OR SKIN DISEASE OR DAMAGE - Methods for the treatment of mood disorders and/or skin disease or damage (eczema, atopic dermatitis, or wrinkles, for example) can comprise administering an extracted prenylflavonoid to a subject experience the mood disorder or the skin disease or damage. | 07-30-2015 |